Showing results (331-340 of 397) with videos related to

Sort By:
Pageof 40
Cell Reports|September 15, 2021
Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human developmentAnindita Roy, Guanlin Wang, Deena Iskander, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 12, 2025
Localization, Proteolytic Processing, and Binding Partners of Versican Isoforms in Vascular Lesions of Pulmonary Arterial HypertensionChristian Westöö, Ayse Ceren Mutgan, Oscar van der Have, et al.
Leukemia|December 5, 2022
Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patientsHosuk Ryou, Korsuk Sirinukunwattana, Alan Aberdeen, et al.
Haematologica|April 13, 2019
Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutationCristina Di Genua, Ruggiero Norfo, Alba Rodriguez-Meira, et al.
Blood|August 5, 2011
Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferationShabnam Kharazi, Adam J Mead, Anna Mansour, et al.
Blood|March 29, 2013
Impact of isolated germline JAK2V617I mutation on human hematopoiesisAdam J Mead, Onima Chowdhury, Christian Pecquet, et al.
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Therapeutic Advances in Hematology|April 4, 2022
A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK studyAdam J Mead, Nauman M Butt, Waseem Nagi, et al.
Cell Reports|June 4, 2013
FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitorsAdam J Mead, Shabnam Kharazi, Deborah Atkinson, et al.
Frontiers in Aging Neuroscience|May 30, 2023
A Y374X TDP43 truncation leads to an altered metabolic profile in amyotrophic lateral sclerosis fibroblasts driven by pyruvate and TCA cycle intermediate alterationsScott P Allen, Afnan Al Sultan, Elaine Kabucho Kibirige, et al.
Pageof 40